Attached files

file filename
8-K - 8-K - Milacron Holdings Corp.pressrelease8-kq32016.htm


Exhibit 99.1
Milacron Holdings Corp. Reports Third Quarter 2016 Results
Strong order performance and solid operating cash flow progression
2016 Third Quarter Overview
 
Sales of $292.2 million increased 0.8%, on a constant currency basis (-1.1% organic, 1.9% acquisition)

Operating earnings (GAAP) were $29.1 million; Adjusted EBITDA (non-GAAP) increased 0.6% to $54.3 million

Diluted EPS (GAAP) of $0.10; Diluted adjusted EPS (non-GAAP) of $0.36

Cash flow from operations of $11.4 million drove free cash flow of $1.5 million, a $10.2 million increase versus $(8.7) million in the prior year

Cincinnati - November 1, 2016 - Milacron Holdings Corp. (“Milacron”) (NYSE: MCRN), a leading industrial technology company serving the plastic processing industry, today announced financial results for the third quarter ended September 30, 2016.
 
Three Months Ended September 30,
In millions (except per share data)
3Q'16
 
3Q'15
 
Change
 
% Change (Constant Currency)
New orders
$
284.3

 
$
275.2

 
3.3
 %
 
4.3
%
Sales
$
292.2

 
$
292.7

 
(0.2
)%
 
0.8
%
Operating earnings
$
29.1

 
$
11.0

 
164.5
 %
 
 
Adjusted EBITDA (1)
$
54.3

 
$
54.0

 
0.6
 %
 
 
% of sales
18.6
%
 
18.4
%
 
+20 bps

 
 
Diluted EPS
$
0.10

 
$
(0.17
)
 
NMF

 
 
Diluted adjusted EPS (1) (2)
$
0.36

 
$
0.37

 
(2.7
)%
 
 
Cash flow from operations
$
11.4

 
$
4.0

 
185.0
 %
 
 
Free cash flow
$
1.5

 
$
(8.7
)
 
$
10.2

 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30,
In millions (except per share data)
2016
 
2015
 
Change
 
% Change (Constant Currency)
New orders
$
900.2

 
$
875.7

 
2.8
 %
 
4.3
%
Sales
$
877.6

 
$
873.2

 
0.5
 %
 
2.0
%
Operating earnings
$
96.8

 
$
38.0

 
154.7
 %
 
 
Adjusted EBITDA (1)
$
159.2

 
$
154.5

 
3.0
 %
 
 
% of sales
18.1
%
 
17.7
%
 
+40 bps

 
 
Diluted EPS
$
0.42

 
$
(0.94
)
 
NMF

 
 
Diluted adjusted EPS (1) (2)
$
1.04

 
$
0.92

 
13.0
 %
 
 
Cash flow from operations
$
60.8

 
$
(5.7
)
 
NMF

 
 
Free cash flow
$
30.6

 
$
(30.6
)
 
$
61.2

 
 
(1) See non-GAAP reconciliations included in the accompanying financial tables for the reconciliation of each non- GAAP measure to its most directly comparable GAAP measure.
(2) Represents fully diluted earnings per share for the three and nine month periods ended September 30, 2015 on a pro-forma basis; calculation uses the total diluted shares used for the three and nine month periods September 30, 2016 (70.2 and 70.0 million shares, respectively).
NMF - Not Meaningful
 
 
 
 
 
 
 








“Despite sales and earnings results that fell below our expectations in the third quarter, our 2016 strategic objectives to create sustainable long-term shareholder value remain on track. said Milacron Chief Executive Officer, Tom Goeke. "Our order trends continued to grow at a solid pace, up 4.3% on a constant currency basis, primarily driven by solid commercial execution in key end markets within our MDCS segment, where our hot runner business recorded double digit order growth and high single digit sales growth for the quarter. Our free cash flow performance continued its strong turnaround from the prior year and our manufacturing footprint optimization plan passed a critical step late in the quarter as we entered into a restructuring plan agreement with local works council, related to the consolidation of our manufacturing facility in Malterdingen, Germany into our expanded APPT facility in the Czech Republic.

The sluggish macroeconomic conditions that have limited growth during the first nine months of 2016 will continue to impact the fourth quarter. However, we remain confident that the strength and balance of our plastics processing portfolio is a key differentiator and positions us to capture growth as we continue to execute on our "Go Forward" plan."

Milacron Chief Financial Officer, Bruce Chalmers, added, "Our adjusted EBITDA for the quarter was below our expectations due to operational inefficiencies, as we manage through the multi year, multi site reorganization and transition to our Czech manufacturing facility, which provided headwinds during the quarter. We also continue to invest ahead of sales through the build out of our APPT aftermarket field service organization and Systems business, which are two key elements of our "Go Forward" plan. These investments are critical for additional sales growth in future periods."

2016 Outlook
Milacron expects its 2016 full-year sales to be between $1,170 to $1,175 million and adjusted EBITDA guidance range to be $209 to $212. Additionally, the Company expects capital expenditures of approximately $45 to $50 million, interest expense to be approximately $60 million, cash taxes to be between $30 to $35 million, an effective tax rate of approximately 30% and shares outstanding to be approximately 70 million.
Third Quarter Results
For the third quarter of 2016, sales of $292.2 million decreased 0.2% from sales of $292.7 million in the same period a year ago. Excluding the unfavorable effects of currency movements and the impact of the CanGen acquisition, organic sales for the third quarter of 2016 decreased 1.1% versus the prior year period. Operating earnings for the third quarter of 2016 increased 164.5% to $29.1 million compared to operating earnings of $11.0 million in the prior year period. Adjusted EBITDA for the third quarter of 2016 increased 0.6% to $54.3 million, or 18.6% of sales, compared to Adjusted EBITDA of $54.0 million, or 18.4% of sales, in the prior year period. Net earnings totaled $6.7 million, or $0.10 per basic and diluted share, in the third quarter of 2016 compared to a net loss of $11.2 million, or a loss of $0.17 per basic and diluted share, in the prior year period. Adjusted net income totaled $25.1 million, or $0.36 per diluted share, in the third quarter of 2016 compared to adjusted net income of $25.7 million in the prior year period.
Year-to-Date Results
For the first nine months of 2016, sales of $877.6 million increased 0.5% from sales of $873.2 million in the same period a year ago. Excluding the unfavorable effects of currency movements and the impact of the CanGen acquisition, organic sales for the first nine months of 2016 increased 0.1% versus the prior year period. Operating earnings for the first nine months of 2016 increased 154.7% to $96.8 million compared to operating earnings of $38.0 million in the prior year period. Adjusted EBITDA for the first nine months of 2016 increased 3.0% to $159.2 million, or 18.1% of sales, compared to Adjusted EBITDA of $154.5 million, or 17.7% of sales, in the prior year period. Net earnings totaled $29.4 million, or $0.44 per basic and $0.42 per diluted share, in the first nine months of 2016 compared to a net loss of $54.3 million, or a loss of $0.94 per basic and diluted share, in the prior year period. Adjusted net income totaled $72.9 million, or $1.04 per diluted share, in the first nine months of 2016 compared to adjusted net income of $64.7 million in the prior year period.
Segment Results
Advanced Plastic Processing Technologies (APPT)
Sales for the third quarter of 2016 were $168.7 million compared to $170.8 million in the same period a year ago. Excluding $1.2 million of unfavorable effects of currency movements, sales decreased 0.5% over the prior year period. Operating earnings for the third quarter of 2016 decreased 30.4% to $11.2 million compared to operating earnings of $16.1 million in the prior year period.





Adjusted EBITDA in the third quarter decreased 0.5% to $21.5 million, or 12.7% of sales, from Adjusted EBITDA of $21.6 million, or 12.6% of sales, in the prior year period.
For the first nine months of 2016, sales were $503.8 million compared to $496.0 million in the same period a year ago. Excluding $5.8 million of unfavorable effects of currency movements, sales increased 2.7% over the prior year period. Operating earnings for the first nine months of 2016 decreased 7.1% to $36.5 million compared to operating earnings of $39.3 million in the prior year period. Adjusted EBITDA for the first nine months was flat at $61.4 million, or 12.2% of sales, versus Adjusted EBITDA of $61.5 million, or 12.4% of sales, in the prior year period.
Melt Delivery & Control Systems (MDCS)
Sales for the third quarter of 2016 were $95.4 million compared to $92.0 million in the same period a year ago. Excluding $0.9 million of unfavorable effects of currency movements, sales increased 4.7% over the prior year period. Operating earnings for the third quarter of 2016 increased 105.0% to $20.5 million compared to operating earnings of $10.0 million in the prior year period. Adjusted EBITDA in the third quarter increased 4.8% to $30.6 million, or 32.1% of sales, from Adjusted EBITDA of $29.2 million, or 31.7% of sales, in the year ago quarter.
For the first nine months of 2016, sales were $288.9 million compared to sales of $289.3 million in the same period a year ago. Excluding $4.6 million of unfavorable effects of currency movements, sales increased 1.5% over the prior year period. Operating earnings for the first nine months of 2016 increased 114.1% to $73.0 million compared to operating earnings of $34.1 million in the prior year period. Adjusted EBITDA for the first nine months increased 5.7% to $94.6 million, or 32.7% of sales, from Adjusted EBITDA of $89.5 million, or 30.9% of sales, in the prior year period.
Fluid Technologies
Sales for the third quarter of 2016 were $28.1 million compared to $29.9 million in the same period a year ago. Excluding $0.6 million of unfavorable effects of currency movements, sales decreased 4.0% over the prior year period. Operating earnings for the third quarter of 2016 increased 51.9% to $4.1 million compared to operating earnings of $2.7 million in the prior year period. Adjusted EBITDA in the third quarter decreased 11.9% to $5.9 million, or 21.0% of sales, from Adjusted EBITDA of $6.7 million, or 22.4% of sales, in the year ago quarter.
For the first nine months of 2016, sales were $84.9 million compared to sales of $87.9 million in the same period a year ago. Excluding $2.3 million of unfavorable effects of currency movements, sales decreased 0.8% over the prior year period. Operating earnings for the first nine months of 2016 increased 41.9% to $13.2 million compared to operating earnings of $9.3 million in the prior year period. Adjusted EBITDA for the first nine months increased 2.2% to $18.5 million, or 21.8% of sales, from Adjusted EBITDA of $18.1 million, or 20.6% of sales, in the prior year period.
Additional Financial Information

Milacron ended the third quarter of 2016 with cash and cash equivalents of $102.7 million and total debt of $953.8 million at September 30, 2016, resulting in net debt of $851.1 million and a net total leverage ratio of 3.9x.

Conference Call
Milacron will host a conference call to discuss its third quarter 2016 financial results at 8 a.m. Eastern Time on November 1, 2016. The live webcast of the call can be accessed at the Milacron Investor Relations website at http://investors.milacron.com, along with the company's earnings press release and related presentation materials. The U.S. dial-in for the call is 1-877-407-8037 (1-201-689-8037 for non-U.S. callers). A replay of the conference call will be available until November 15, 2016 at 11:59 p.m. Eastern Time, while an archived version of the webcast will be available on the Milacron Investor Relations website for 90 days. The U.S. dial-in for the conference call replay is 1-877-660-6853 (1-201-612-7415). The replay access code is 13635788.
About Milacron
Milacron is a global leader in the manufacture, distribution and service of highly engineered and customized systems within the plastic technology and processing industry. Milacron is the only global company with a full-line product portfolio that includes hot runner systems, injection molding, blow molding and extrusion equipment.






Forward-Looking Statements
This press release contains forward-looking statements. The words “believe,” “expect,” “anticipate,” "plan," “intend,” "should," “estimate” and other expressions that are predictions of or indicate future events and trends and that do not relate to historical matters identify forward-looking statements. You should not place undue reliance on these forward-looking statements. Although forward-looking statements reflect management’s good faith beliefs, reliance should not be placed on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to differ materially from anticipated future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements speak only as of the date the statements are made. Except as required by law, Milacron undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise. These forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to demand for our products being significantly affected by general economic conditions, any decline in the use of plastic, the competitiveness of the industries in which we operate and the financial resources of our competitors, our ability to successfully develop and implement strategic initiatives to increase cost savings and improve operating margins and the other risk factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2015, as filed with the SEC on March 2, 2016, and other SEC filings, copies of which are available free of charge on our website at investors.milacron.com.

Non-GAAP Financial Measures

We prepare our financial statements in conformity with United States generally accepted accounting principles ("U.S. GAAP"). To supplement this information, we also use the following non-GAAP financial measures: Adjusted EBITDA and Adjusted Net Income. Because not all companies use identical calculations, these presentations may not be comparable to other similarly titled measures of other companies.

Adjusted EBITDA

Adjusted EBITDA represents net income before interest expense, taxes, depreciation and amortization, as further adjusted for the other items reflected in the reconciliation table set forth below. Adjusted EBITDA is a measure used by management to measure operating performance. Adjusted EBITDA is not a presentation made in accordance with U.S. GAAP, is not a measure of financial condition or profitability, and should not be considered as an alternative to net earnings (loss) determined in accordance with U.S. GAAP or operating cash flows determined in accordance with U.S. GAAP or any other performance measure derived in accordance with U.S. GAAP and should not be construed as an inference that our future results will be unaffected by unusual non-recurring items. Additionally, Adjusted EBITDA is not intended to be a measure of free cash flow for management’s discretionary use, as it does not include certain cash requirements such as interest payments, tax payments, debt service requirements and certain other cash costs that may recur in the future.

We view Adjusted EBITDA as a key measure of our performance. We present Adjusted EBITDA not only due to its importance for purposes of our credit agreements but also because it assists us in comparing our performance across reporting periods on a consistent basis as it excludes items that we do not believe are indicative of our core operating performance. Our management uses Adjusted EBITDA:
as a measurement used in evaluating our consolidated and segment-level operating performance on a consistent basis;
to calculate incentive compensation for our employees
for planning purposes, including the preparation of our internal annual operating budget;
to evaluate the performance and effectiveness of our operational strategies; and
to assess compliance with various metrics associated with our debt agreements.

We believe that the inclusion of Adjusted EBITDA is useful to provide additional information to investors about certain material non-cash items as well as items considered to be one-time or non-recurring to the operations of the business. While we believe these financial measures are commonly used by investors to evaluate our performance and that of our competitors, because not all companies use identical calculations, this presentation of Adjusted EBITDA may not be comparable to other similarly titled measures of other companies and should not be considered as an alternative to performance measures derived in accordance with U.S. GAAP. Adjusted EBITDA is calculated as net earnings (loss) before income tax expense, interest expense, net, depreciation and amortization further adjusted to exclude other items as reflected in the reconciliation table below.






In evaluating Adjusted EBITDA, you should be aware that in the future we will incur expenses such as those used in calculating Adjusted EBITDA. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by usual or non-recurring items. Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business. We compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA only supplementary.
Adjusted Net Income

Adjusted Net Income measures our operating performance by adjusting net earnings (loss) to exclude amortization expense, non-cash currency effect on intercompany loans, organizational redesign costs, long-term equity awards and shareholder fees, acquisition integration costs, professional services and certain other non-recurring items. Management uses this measure to evaluate our core operating results as it excludes certain items whose fluctuations from period-to-period do not necessarily correspond to changes in the core operations of the business, but includes certain items such as depreciation, interest expense and interest tax expense, which are otherwise excluded from Adjusted EBITDA. We believe the presentation of Adjusted Net Income enhances our investors’ overall understanding of the financial performance and cash flow of our business. You should not consider Adjusted Net Income as an alternative to net earnings (loss), determined in accordance with U.S. GAAP, as an indicator of operating performance.

Adjusted Earnings Per Share

Adjusted Earnings Per Share is defined as Adjusted Net Income divided by diluted weighted average shares outstanding. We believe Adjusted Earnings Per Share is useful to investors because it measures our operating performance, on a per share basis, by adjusting net earnings (loss), on a per share basis, to exclude amortization expense, non-cash currency effect on intercompany loans, organizational redesign costs, long-term equity awards and shareholder fees, acquisition integration costs, professional services and certain other non-recurring items. We believe the presentation of Adjusted Earnings Per Share enhances our investors’ overall understanding of the financial performance and cash flow of our business. You should not consider Adjusted Earnings Per Share as an alternative to earnings per share, determined in accordance with U.S. GAAP, as an indicator of operating performance.

Contacts:

For more information, contact:
Investor Relations Contact:
Mac Jones, Milacron
Mac_Jones@milacron.com
513-487-5057

Media Contact:
Michael Ellis, Milacron
Michael_Ellis@milacron.com
905-877-0185 ext. 354









MILACRON HOLDINGS CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS
 
 
September 30, 2016
(Unaudited)
 
December 31, 2015
 
(in millions)
Assets
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
102.7

 
$
67.5

Accounts receivable, net
199.1

 
204.4

Inventories, net:
 
 
 
Raw materials
82.1

 
81.1

Work-in-process
51.1

 
48.3

Finished products
118.9

 
109.5

Total inventories
252.1

 
238.9

Prepaid and other current assets
53.9

 
38.6

Total current assets
607.8

 
549.4

Property and equipment, net
223.3

 
221.8

Goodwill
527.2

 
530.1

Intangible assets, net
362.0

 
380.1

Other noncurrent assets
11.2

 
14.9

Total assets
$
1,731.5

 
$
1,696.3

Liabilities and shareholders’ equity
 
 
 
Current liabilities:
 
 
 
Short-term borrowings
$
7.4

 
$
7.4

Long-term debt and capital lease obligations due within one year
0.1

 
0.4

Accounts payable
78.2

 
79.2

Advanced billings and deposits
48.8

 
39.7

Accrued salaries, wages and other compensation
24.3

 
30.8

Accrued interest
4.9

 
13.9

Other current liabilities
59.1

 
52.5

Total current liabilities
222.8

 
223.9

Long-term debt and capital lease obligations
933.6

 
931.9

Deferred income tax liabilities
64.4

 
66.2

Accrued pension liabilities
25.7

 
25.2

Other noncurrent accrued liabilities
9.1

 
8.2

Total liabilities
1,255.6

 
1,255.4

Shareholders’ equity:
 
 
 
Preferred stock

 

Common stock
0.7

 
0.7

Capital in excess of par value
656.9

 
648.7

Retained deficit
(70.0
)
 
(99.4
)
Accumulated other comprehensive loss
(111.7
)
 
(109.1
)
Total shareholders’ equity
475.9

 
440.9

Total liabilities and shareholders’ equity
$
1,731.5

 
$
1,696.3











MILACRON HOLDINGS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
 
(in millions, except share and per share data)
 
 
 
 
 
 
 
 
Net sales
$
292.2

 
$
292.7

 
$
877.6

 
$
873.2

Cost of sales
192.5

 
191.4

 
574.5

 
569.8

Manufacturing margins
99.7

 
101.3

 
303.1

 
303.4

Operating expenses:
 
 
 
 
 
 
 
Selling, general and administrative expenses
60.3

 
69.2

 
187.0

 
207.5

Amortization expense
7.8

 
8.7

 
23.5

 
27.3

(Gain) loss on currency translation
(0.3
)
 
8.7

 
(8.3
)
 
18.6

Other expense, net
2.8

 
3.7

 
4.1

 
12.0

Total operating expenses
70.6

 
90.3

 
206.3

 
265.4

Operating earnings
29.1

 
11.0

 
96.8

 
38.0

Interest expense, net
15.2

 
15.6

 
45.6

 
52.4

Loss on debt extinguishment

 

 

 
22.2

Earnings (loss) before income taxes
13.9

 
(4.6
)
 
51.2

 
(36.6
)
Income tax expense
7.2

 
6.6

 
21.8

 
17.7

Net earnings (loss)
$
6.7

 
$
(11.2
)
 
$
29.4

 
$
(54.3
)
 
 
 
 
 
 
 
 
Weighted average shares outstanding:
 
 
 
 
 
 
 
Basic
67,567,671

 
66,900,081

 
67,389,370

 
57,529,038

Diluted
70,228,702

 
66,900,081

 
70,019,487

 
57,529,038

 
 
 
 
 
 
 
 
Earnings (loss) per share:
 
 
 
 
 
 
 
Basic
$
0.10

 
$
(0.17
)
 
$
0.44

 
$
(0.94
)
Diluted
$
0.10

 
$
(0.17
)
 
$
0.42

 
$
(0.94
)



























MILACRON HOLDINGS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
 
Nine Months Ended September 30,
 
2016
 
2015
 
( in millions)
Operating activities
 
 
 
Net earnings (loss)
$
29.4

 
$
(54.3
)
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:
 
 
 
Depreciation and amortization
44.8

 
47.0

Unrealized (gain) loss on currency translation of intercompany advances
(7.3
)
 
19.6

Amortization of deferred financing costs
2.8

 
3.1

Loss on debt extinguishment

 
8.4

Asset impairments
1.4

 
2.2

Non-cash stock-based compensation expense
4.0

 
19.7

Deferred income taxes
(0.4
)
 
0.8

Changes in assets and liabilities:
 
 
 
Accounts receivable
6.3

 
(18.6
)
Inventories
(12.0
)
 
(21.2
)
Prepaid and other current assets
(8.5
)
 
2.2

Accounts payable
0.2

 
1.3

Advanced billings and deposits
8.6

 
(12.7
)
Other current liabilities
(12.7
)
 
(0.6
)
Other noncurrent assets
3.4

 
(1.5
)
Other noncurrent accrued liabilities
0.8

 
(1.1
)
Net cash provided by (used in) operating activities
60.8

 
(5.7
)
Investing activities
 
 
 
Purchases of property and equipment
(31.0
)
 
(39.7
)
Proceeds from disposals of property and equipment
0.8

 
1.0

Net cash used in investing activities
(30.2
)
 
(38.7
)
Financing activities
 
 
 
Proceeds from issuance of long-term debt (original maturities longer than 90 days)

 
795.3

Payments on long-term debt and capital lease obligations (original maturities longer than 90 days)
(0.7
)
 
(874.0
)
Net increase (decrease) in short-term borrowings (original maturities of 90 days or less)
0.1

 
(1.4
)
Dividends paid

 
(144.6
)
Proceeds from issuance of common stock

 
294.0

Initial public offering issuance costs

 
(21.1
)
Proceeds from exercise of stock options
4.2

 
0.4

Debt issuance costs

 
(7.0
)
Net cash provided by financing activities
3.6

 
41.6

Effect of exchange rate changes on cash
1.0

 
(4.2
)
Increase (decrease) in cash and cash equivalents
35.2

 
(7.0
)
Cash and cash equivalents at beginning of period
67.5

 
81.5

Cash and cash equivalents at end of period
$
102.7

 
$
74.5










MILACRON HOLDINGS CORP.

SALES BY BUSINESS SEGMENT
(Unaudited)
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
 
( in millions)
Sales by segment:
 
 
 
 
 
 
 
Advanced Plastic Processing Technologies
$
168.7

 
$
170.8

 
$
503.8

 
$
496.0

Melt Delivery and Control Systems
95.4

 
92.0

 
288.9

 
289.3

Fluid Technologies
28.1

 
29.9

 
84.9

 
87.9

Total
$
292.2

 
$
292.7

 
$
877.6

 
$
873.2


















































MILACRON HOLDINGS CORP.

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(Unaudited)
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
 
(in millions)
Net earnings (loss)
$
6.7

 
$
(11.2
)
 
$
29.4

 
$
(54.3
)
Amortization expense
7.8

 
8.7

 
23.5

 
27.3

Currency effect on intercompany advances (a)

 
9.4

 
(7.3
)
 
19.6

Organizational redesign costs (b)
5.8

 
4.9

 
14.7

 
15.8

Long-term equity awards and shareholder fees (c)
2.2

 
12.3

 
5.2

 
23.4

Debt costs (d)

 
0.1

 

 
23.2

Acquisition integration costs (e)

 
(0.3
)
 

 
3.2

Professional services (f)
0.4

 
1.6

 
2.5

 
4.3

Fair market value adjustments (g)

 

 
0.3

 

Annual effective tax rate adjustment (h)
0.4

 

 
2.4

 

Other (i)
1.8

 
0.2

 
2.2

 
2.2

Adjusted Net Income
$
25.1

 
$
25.7

 
$
72.9

 
$
64.7

Income tax expense (h)
6.8

 
6.6

 
19.4

 
17.7

Interest expense, net
15.2

 
15.6

 
45.6

 
52.4

Depreciation expense
7.2

 
6.1

 
21.3

 
19.7

Adjusted EBITDA
$
54.3

 
$
54.0

 
$
159.2

 
$
154.5

 

(a)
Non-cash currency effect on intercompany advances primarily relates to advances denominated in foreign currencies. The most significant exposure relates to the Canadian dollar pursuant to intercompany advances within the MDCS segment.

(b)
Organizational redesign costs in the three months ended September 30, 2016 primarily included $1.4 million for termination costs as a result of eliminated positions, $2.0 million of costs related to the shutdown of facilities and $0.3 million of costs related to the restructuring of Fluids in Europe. Organizational redesign costs in the nine months ended September 30, 2016 primarily included $4.7 million for termination costs as a result of eliminated positions, $4.4 million of costs related to the shutdown of facilities, $0.5 million of costs related to relocating our facility in Belgium to the Czech Republic and $0.3 million of costs related to the restructuring of Fluids in Europe. Organizational redesign costs in the three months ended September 30, 2015 primarily included $1.5 million of severance and $0.8 million of one-time project costs related to the restructuring of Fluids in Europe, $1.0 million for termination costs as a result of eliminated positions, $0.5 million of costs related to the restructuring of the procurement organization, and $0.4 million of costs related to relocating our facility in Italy to the Czech Republic. Organizational redesign costs in the nine months ended September 30, 2015 primarily included $3.8 million of severance and $2.9 million of one-time project costs related to relocating our facilities in Belgium and Italy to the Czech Republic, $3.3 million for termination costs as a result of eliminated positions, $2.8 million of costs related to the restructuring of Fluids in Europe, and $0.7 million of costs related to the restructuring of the procurement organization.

(c)
Long-term equity awards and shareholder fees include the charges associated with stock-based compensation awards granted to certain executives and independent directors and a cash advisory fee paid to CCMP in the three and nine months ended September 30, 2016 and 2015. The cash advisory payment to CCMP ceased as of the effective date of our IPO.

(d)
Debt costs incurred during the nine months ended September 30, 2015 included $22.2 million of debt extinguishment costs and $0.9 million of fees related to the new senior secured term loan facility due September 2020 ("New Term Loan Facility").

(e)
Acquisition integration costs in the three months ended September 30, 2015 included a $0.4 million gain for the adjustment to an accrued incentive payment. In the nine months ended September 30, 2015, we incurred $1.5 million of costs to introduce the integration and new branding of all Milacron companies. In addition, acquisition integration costs in the nine months ended September 30, 2015 included $1.5 million of costs related to the Kortec, Inc. ("Kortec"), TIRAD s.r.o. ("TIRAD") and Mold-Masters acquisitions for product line integration and other strategic alignment initiatives.

(f)
Professional fees in the three and nine months ended September 30, 2016 included $0.4 million and $2.5 million, respectively, of costs for strategic organizational initiatives. Professional fees related to operational efficiency, business development, and other one-time advisory projects in the three and nine months ended September 30, 2015 included $0.4 million and $2.6 million of fees for readiness initiatives associated with our IPO and $0.7 million and $1.0 million of costs for strategic organizational initiatives, respectively.

(g)
Non-cash fair market value adjustments relate to acquisition accounting for the fair market value of inventory as part of our acquisition of CanGen in the fourth quarter of 2015.






(h)
The annual effective tax rate adjustment primarily includes the impact to the tax provision utilizing the annual effective tax rate recomputed with anticipated tax rate reductions that have not been recognized for U.S. GAAP purposes as the Company is awaiting regulatory approval.  The reductions have historically been approved, or are expected to be approved, although there are no guarantees that the regulatory authorities will accept the Company’s applications. In addition, the adjustment includes the impact of interim and intra-period tax expense and benefits that are expected to reverse in subsequent periods as well as the tax benefit associated with reconciling net earnings (loss) to Adjusted Net Income.

(i)
Other costs for the three and nine months ended September 30, 2016 includes $1.4 million related to the impairment of certain software licenses. Other costs for the nine months ended September 30, 2016 includes the write-off of a $0.5 million non-trade receivable. Other costs for the nine months ended September 30, 2015 include a non-cash charge of $2.2 million related to the impairment of certain trademarks.

























































MILACRON HOLDINGS CORP.
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES(Unaudited) 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
 
(in millions)
Operating earnings (loss):
 
 
 
 
 
 
 
APPT
$
11.2

 
$
16.1

 
$
36.5

 
$
39.3

MDCS
20.5

 
10.0

 
73.0

 
34.1

Fluids
4.1

 
2.7

 
13.2

 
9.3

Corporate
(6.7
)
 
(17.8
)
 
(25.9
)
 
(44.7
)
Total operating earnings
29.1

 
11.0

 
96.8

 
38.0

Adjustments to operating earnings:
 
 
 
 
 
 
 
APPT Adjustments:
 
 
 
 
 
 
 
Depreciation and amortization
5.0

 
4.5

 
15.0

 
14.9

Currency effect on intercompany advances (a)
(0.1
)
 

 
(0.1
)
 

Organizational redesign costs (b)
4.0

 
1.0

 
8.2

 
4.0

Acquisition integration costs (e)

 

 

 
0.9

Professional services (f)

 

 
0.1

 
0.2

Fair market value adjustments (g)

 

 
0.3

 

Other (h)
1.4

 

 
1.4

 
2.2

Total APPT Adjustments
10.3

 
5.5

 
24.9

 
22.2

MDCS Adjustments:
 
 
 
 
 
 
 
Depreciation and amortization
8.4

 
8.6

 
25.1

 
26.8

Currency effect on intercompany advances (a)
0.4

 
9.4

 
(6.7
)
 
19.4

Organizational redesign costs (b)
1.1

 
1.1

 
3.0

 
7.2

Acquisition integration costs (e)

 
(0.4
)
 

 
1.7

Professional services (f)

 
0.3

 
0.1

 
0.3

Other (h)
0.2

 
0.2

 
0.1

 

Total MDCS Adjustments
10.1

 
19.2

 
21.6

 
55.4

Fluids Adjustments:
 
 
 
 
 
 
 
Depreciation and amortization
1.4

 
1.6

 
4.1

 
5.0

Organizational redesign costs (b)
0.3

 
2.4

 
0.6

 
3.7

Professional services (f)

 

 

 
0.1

Other (h)
0.1

 

 
0.6

 

Total Fluids Adjustments
1.8

 
4.0

 
5.3

 
8.8

Corporate Adjustments:
 
 
 
 
 
 
 
Depreciation and amortization
0.2

 
0.1

 
0.6

 
0.3

Currency effect on intercompany advances (a)
(0.3
)
 

 
(0.5
)
 
0.2

Organizational redesign costs (b)
0.4

 
0.4

 
2.9

 
0.9

Long-term equity awards and shareholder fees (c)
2.2

 
12.3

 
5.2

 
23.4

Debt costs (d)

 
0.1

 

 
1.0

Acquisition integration costs (e)

 
0.1

 

 
0.6

Professional services (f)
0.4

 
1.3

 
2.3

 
3.7

Other (h)
0.1

 

 
0.1

 

Total Corporate Adjustments
3.0

 
14.3

 
10.6

 
30.1

Adjusted EBITDA:
 
 
 
 
 
 
 
APPT
21.5

 
21.6

 
61.4

 
61.5

MDCS
30.6

 
29.2

 
94.6

 
89.5

Fluids
5.9

 
6.7

 
18.5

 
18.1

Corporate
(3.7
)
 
(3.5
)
 
(15.3
)
 
(14.6
)
Total Adjusted EBITDA
$
54.3

 
$
54.0

 
$
159.2

 
$
154.5







(a)
Non-cash currency effect on intercompany advances primarily relates to advances denominated in foreign currencies. The most significant exposure relates to the Canadian dollar pursuant to intercompany advances within the MDCS segment.

(b)
Organizational redesign costs in the three months ended September 30, 2016 primarily included $2.0 million of costs related to the shutdown of facilities in APPT, $1.4 million for termination costs as a result of eliminated positions across all segments and $0.3 million of costs related to the restructuring of Fluids in Europe. Organizational redesign costs in the nine months ended September 30, 2016 included $4.4 million of costs related to the shutdown of facilities in APPT, $0.5 million of costs related to relocating our facility in Belgium to the Czech Republic in MDCS and $0.3 million of costs related to the restructuring of Fluids in Europe. In the nine months ended September 30, 2016, organizational redesign costs across all segments included $4.7 million for termination costs as a result of eliminated positions. Organizational redesign costs in APPT in the three months ended September 30, 2015 included $0.4 million of costs related to relocating our facility in Italy to the Czech Republic and $0.2 million of costs related to the restructuring of the procurement organization. Organizational redesign costs incurred in MDCS in the three months ended September 30, 2015 included $0.8 million for termination costs as a result of eliminated positions. Organizational redesign costs incurred in Fluids during the three months ended September 30, 2015 included $1.5 million of severance and $0.8 million of one-time project costs related to restructuring in Europe. In the nine months ended September 30, 2015, organizational redesign costs in the APPT and MDCS segments included $2.0 million and $4.7 million for costs related to relocating our facilities in Italy and Belgium to the Czech Republic, respectively. As incurred at the respective segments, organizational redesign costs in the nine months September 30, 2015 included $3.3 million for termination costs as a result of eliminated positions. Organizational redesign costs for Fluids during the nine months ended September 30, 2015 included $2.8 million of severance and one-time project costs related to restructuring in Europe.

(c)
Long-term equity awards and shareholder fees in Corporate include the charges associated with stock-based compensation awards granted to certain executives and independent directors and a cash advisory fee paid to CCMP during the three and nine months ended September 30, 2016 and 2015. The cash advisory payment to CCMP ceased as of the effective date of our IPO.

(d)
Debt costs incurred during the nine months ended September 30, 2015 included $0.9 million of fees related to the New Term Loan Facility.

(e)
Acquisition integration costs for MDCS in the three months ended September 30, 2015 included a $0.4 million gain for an adjustment to an accrued incentive payment. Acquisition integration costs for MDCS in the nine months ended September 30, 2015 include $1.5 million related to the Kortec, TIRAD and Mold-Masters acquisitions for product line integration and other strategic alignment initiatives. In addition, APPT and Corporate acquisition integration costs for the nine months ended September 30, 2015 include $0.7 million and $0.6 million of one-time costs to introduce the integration and new branding of all Milacron companies, respectively.

(f)
Professional fees incurred by Corporate in the three and nine months ended September 30, 2016 included $0.4 million and $2.5 million of costs for strategic organizational initiatives, respectively. Professional fees incurred by Corporate in the three and nine months ended September 30, 2015 included $0.3 million and $2.4 million for readiness initiatives related to our IPO, respectively. In addition, professional fees incurred by Corporate in the three and nine months ended September 30, 2015 included $0.6 million and $0.9 million of costs for strategic organizational initiatives, respectively.

(g)
Non-cash fair market value adjustments relate to acquisition accounting for the fair market value of inventory as part of our acquisition of CanGen in the fourth quarter of 2015.
(h)
Other costs for APPT for the three and nine months ended September 30, 2016 includes $1.4 million related to the impairment of certain software licenses. Other costs for Fluids for the nine months ended September 30, 2016 includes the write-off of a $0.5 million non-trade receivable. Other costs for APPT for the nine months ended September 30, 2015 included a non-cash charge of $2.2 million related to the impairment of certain trademarks.



























MILACRON HOLDINGS CORP.

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(Unaudited)
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2016
 
2015
 
2016
 
2015
 
(in millions, except per share data)
GAAP diluted earnings (loss) per share (a)
$
0.10

 
$
(0.16
)
 
$
0.42

 
$
(0.78
)
Amortization expense
0.11

 
0.12

 
0.34

 
0.39

Currency effect on intercompany advances

 
0.13

 
(0.10
)
 
0.28

Organizational redesign costs
0.08

 
0.07

 
0.21

 
0.23

Long-term equity awards and shareholder fees
0.03

 
0.18

 
0.07

 
0.33

Debt costs

 

 

 
0.33

Acquisition integration costs

 

 

 
0.05

Professional services
0.01

 
0.02

 
0.04

 
0.06

Annual effective tax rate adjustment
0.01

 

 
0.03

 

Other
0.02

 
0.01

 
0.03

 
0.03

Adjusted diluted earnings per share (a)
$
0.36

 
$
0.37

 
$
1.04

 
$
0.92


(a)
Represents fully diluted earnings (loss) per share for the three and nine month periods ended September 30, 2015 on a pro-forma basis; calculation uses the total diluted shares used for the three and nine month periods ended September 30, 2016 (70.2 and 70.0 million shares, respectively).